RecruitingNCT03144648

PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women

Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women (PRECAMA): a Multicenter Population-based Case-control Study


Sponsor

International Agency for Research on Cancer

Enrollment

3,000 participants

Start Date

Oct 12, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

Breast cancer has become a major public health problem in Latin America, as it is the most common form of cancer among women. Women are more likely to develop breast cancer at younger age, and to be diagnosed at an advanced stage compared to western women. Over the past twenty years, the mortality from breast cancer in Latin America has also been increasing very rapidly, and is currently the leading cause of cancer mortality. Little is known on specific risk factors for premenopausal breast cancer in general, and in Latin America in particular. There is a lack of specific knowledge on tumor molecular and pathological characteristics of breast cancer in Latin America premenopausal women, and this has major consequences on cancer treatment and survival. To improve our understanding on determinants of breast cancer incidence and mortality in young Latin America women and support preventive actions, we implemented an international, population-based multi-center study in Latin America: the PRECAMA study (Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women (PRECAMA): a multicenter population-based case-control study). PRECAMA is coordinated by the International Agency for Research on Cancer (IARC), and is conducted within 4 Latin American countries: Mexico, Costa Rica, Colombia and Chile. Major aims of the project are the following: 1. To develop a multi-centric population-based case-control study on breast cancer in premenopausal women in several countries in Latin America with structured collection of individual, clinical, pathological information and biological specimens, according to strictly controlled protocols 2. To characterize, in these populations, the subtypes of premenopausal breast cancer on the basis of their molecular and pathological phenotypes 3. To improve the identification of specific endogenous/exogenous factors, and disentangle the interplay of these different factors with regard to breast tumor subtypes. 4. Provide advanced training, induce a structuring effect on the breast cancer research community in Latin America and influence the public health agenda regarding the management of breast cancer. The results of our study will be of utmost importance to understand the etiology of breast cancer in Latin America countries, and would provide important information on the role of modifiable exposures for breast cancer prevention.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at the molecular and genetic subtypes of breast cancer in younger women from Latin America who have not yet gone through menopause, to better understand how breast cancer in this population differs from other groups. **You may be eligible if...** - You are a woman between 20 and 45 years old - You have been diagnosed with breast cancer confirmed by a tissue biopsy (if you are a case participant) - OR you are a healthy woman without breast cancer who matches the age of a case participant (if you are a control participant) - You have had at least one menstrual period in the past 12 months - You have lived in the study area for at least the past 3 years **You may NOT be eligible if...** - You are currently receiving cancer treatment such as radiation, chemotherapy, or hormone-blocking therapy - You are already menopausal - You do not live in the designated study area Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERlifestyle

Observational study


Locations(13)

Barretos Cancer Hospital

Barretos, Brazil

INC

Santiago, Independencia, Chile

Hso-Crsco

Santiago, Peñalolén, Chile

FALP

Santiago, Providencia, Chile

Grupo Infección y Cáncer. Universidad de Antioquia

Medellín, Antioquia, Colombia

International Hospital of Colombia

Bucaramanga, Bucaramanga, Colombia

Facultad de Medicina, Universidad del Norte

Barranquilla, Colombia

Hospital Internacional de Colombia Fundacion Cardiovascular de Colombia

Bucaramanga, Colombia

SENOSAMA foundation

Bucaramanga, Colombia

Instituto de Oncología HematoOncologos

Cali, Colombia

Public Health University of Narino

Pasto, Colombia

Agencia Costarricense de Investigaciones Biomédicas (ACIB)

San José, Provincia de San José, Costa Rica

Instituto Nacional de Salud Pública (INSP)

Cuernavaca, Morelos, Mexico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03144648


Related Trials